Albiglutide Completed Phase 1 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00394030Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
NCT02660736Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects